Synexus appoints Germany and Poland managers

May 11, 2010
Research and Development CRO, Synexus, appointment, research and development

Synexus has appointed Dr Helena Sigal as country manager for Germany and Radoslaw Janiak as country manager for Poland. Helena …

EMA transparency criticised

May 11, 2010
Sales and Marketing EMA, Roaccutane, patient information

The European Medicines Agency (EMA) has been given a rap over the knuckles by the European Ombudsman for a perceived …

Calls for changes to trial publication process

May 11, 2010
Medical Communications, Research and Development industry relations, industry reputation, publication

Clinical trial publishing has not kept pace with changes in the way pharma carries out its research, according to a …

Crucell malaria vaccine starts trials in Africa

May 11, 2010
Research and Development Crucell, malaria

Dutch biopharma firm Crucell has started a phase I trial of its AdVac-based malaria vaccine in Burkina Faso, West Africa. …

Pfizer to cut jobs in New York

May 11, 2010
Sales and Marketing Pfizer, job cuts

Pfizer is reportedly planning to cut or relocate up to 1,400 jobs in New York in its on-going restructuring programme. …

Doctors shunning pharma rep visits

May 11, 2010
pharma, sales force, sales force effectiveness, sales representatives

More and more doctors in the US are refusing to see pharma companies’ sales representatives, according to new research. The …

Bayer colon cancer drug moves into phase III

May 11, 2010
Research and Development Bayer, colorectal cancer, regorafenib

Bayer Schering Pharma will shortly begin phase III tests of its investigational compound regorafenib for patients with metastatic colorectal cancer.  …

Merck gains rights to cancer treatment

May 10, 2010
Research and Development Ariad Pharmaceuticals, Merck & Co, NSCLC

Merck has acquired an exclusive license for a new cancer drug that’s in trials for a number of different forms …

Anti-counterfeiting pilot a success, says EFPIA

May 10, 2010
Sales and Marketing counterfeits, supply chain

A pilot project aimed at stopping counterfeit medicines getting into the supply chain has been a resounding success, according to …

Teva reports strong Q1 results

May 10, 2010
Sales and Marketing 2010 financials, Teva

Generics firm Teva Pharmaceuticals has reported strong first quarter results, driven by its patented multiple sclerosis therapy Copaxone. Sales of …

Professor Sander van Deventer appointed to AMT supervisory board

May 10, 2010
Research and Development AMT, Amsterdam Molecular Therapeutics, appointment, research and development

Dutch human gene therapy company Amsterdam Molecular Therapeutics has appointed Professor Sander van Deventer to its supervisory board. One of …

Pharma manufacturing news in brief

May 10, 2010
Manufacturing and Production American Peptide, DSM Biologics, Dutch CMO SynCo Bio Partners, KV Pharmaceutical, Merck & Co, manufacturing

This week’s round-up of pharmaceutical manufacturing news includes facility updates from KV Pharmaceutical, DSM Biologics, Merck & Co and American …

In search of a real solution to the counterfeit problem

May 10, 2010
Manufacturing and Production Plavix, counterfeits, supply chain

For a great deal of the last decade, warnings from the pharmaceutical industry about the growing threat of counterfeit medicines …

Boehringer signs antibody myeloma R&D deal

May 10, 2010
Research and Development Boehringer, Cancer, Micromet, myeloma

Boehringer Ingelheim and US biotech company Micromet are to research and develop a new BiTE antibody to treat multiple myeloma. …

Lundbeck delivers strong results and builds on pipeline

May 7, 2010
2010 financials, Azilect, Lundbeck

Denmark-based Lundbeck has seen a large jump in revenue for the first quarter thanks to steady growth from its lead …

European court backs prescribing incentives

May 7, 2010
Sales and Marketing prescribing incentives

Payments to persuade UK doctors to prescribe generics have been backed by a European court, thwarting pharma attempts to have …

CML Alliance

Digital Pharma: Novartis rebuked for “false and misleading” websites

May 7, 2010
Medical Communications disease awareness campaigns

The FDA has issued Novartis with a stern warning over two websites it sponsors, saying it considers gistalliance.com and cmlalliance.com …

Mixed fortunes for major CROs in Q1

May 7, 2010
Research and Development CRO, Covance, ICON, PPD, Parexel, contact research, contract research, contract research organisation

Leading contract research organisations (CROs) reported a mixed bag of financial results for the first three months of 2010, although …

Blood clot

Encouraging data for ThromboGenics and BioInvent product

May 7, 2010
BioInvent, Lovenox, ThromboGenics, VTE

An antibody-based drug to prevent blood clots after orthopaedic surgery has shown promising results in phase II. TB-402 is a …

Congress to probe McNeil’s GMP violations

May 7, 2010
Manufacturing and Production Johnson & Johnson, McNeil, manufacturing compliance

The US Food and Drug Administration may take additional regulatory action against Johnson & Johnson subsidiary McNeil Consumer Healthcare over …

The Gateway to Local Adoption Series

Latest content